HOWSON TAMAR D

CIK 000120228612 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001202286

Recent Transactions

50 trades

Award
IMMUNIC, INC.$IMUX
Stock Option
2025-06-05+150,000→ 150,000 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2024-06-11+100,000→ 100,000 total
Disposition to Issuer
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04−10,000→ 0 total
Disposition to Issuer
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04−15,000→ 0 total
Disposition to Issuer
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04−19,973→ 0 total
Disposition to Issuer
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04−9,986→ 0 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04+64,959→ 64,959 total
Disposition to Issuer
IMMUNIC, INC.$IMUX
Stock Option
2024-03-04−10,000→ 0 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2023-09-29+10,000→ 10,000 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2023-06-28+16,000→ 16,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-01-03+10,000→ 10,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2022-07-05+87,500→ 87,500 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2022-06-15+10,000→ 10,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2022-01-03+10,000→ 10,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2021-07-01+50,000→ 50,000 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2021-06-10+10,000→ 10,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-01-04+10,000→ 10,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-09-17+50,000→ 50,000 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2020-07-02+15,000→ 15,000 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2020-07-02+50,000→ 50,000 total
Award
IMMUNIC, INC.$IMUX
Stock Option
2019-10-11+29,959→ 29,959 total
Award
Lite Strategy, Inc.$LITS
Stock Option (Right to Buy)
2019-07-01+60,000→ 60,000 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2018-07-26+45,500→ 45,550 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2017-08-24+42,500→ 42,500 total
Award
Hepion Pharmaceuticals, Inc.$HEPA
Stock Options
2017-04-10+35,000→ 80,000 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2016-08-17+18,500→ 18,500 total
Award
VivoSim Labs, INC.$VIVS
Common Stock
2016-08-17+7,500→ 7,500 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2015-08-20+37,000→ 37,000 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Stock Option (Right to Buy)
2015-05-28+77,996→ 77,996 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2015-03-17$307.51/sh−549→ 1,539 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2014-08-20+31,500→ 31,500 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−3,333→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−20,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−20,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−20,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−15,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−20,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−20,000→ 0 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Stock Option (Right to Buy)
2014-07-02+5,280→ 5,280 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Stock Option (Right to Buy)
2014-01-02+4,880→ 4,880 total
Sale
Allergan plc
Ordinary Shares
2013-11-06$157.34/sh+300→ 946 total
Award
Allergan plc
Ordinary Shares
2013-10-01+1,246→ 1,246 total
Disposition to Issuer
Warner Chilcott plc
Ordinary shares, par value $0.01 per share
2013-09-30−4,170→ 0 total
Disposition to Issuer
Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
2013-09-30−14,680→ 0 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2013-08-21+30,500→ 30,500 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Common Stock, $0.01 par value per share
2013-07-01+3,703→ 8,761 total
Award
Oncotelic Therapeutics, Inc.$OTLC
Stock Option (Right to Buy)
2013-07-01+5,030→ 5,030 total
Award
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2013-06-06+20,000→ 20,000 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2013-06-05+45,500→ 45,500 total
Award
Warner Chilcott plc
Ordinary shares, par value $0.01 per share
2013-05-07+4,170→ 4,170 total

Companies

Recent Filings

Address

C/O: OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov